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INTRODUCTION 
Monoamine Oxidase (MAO) has proven to be most problematic 
for both basic scientists and clinicians. The review of the 
literature is organized in'terms of the techniques used to 
elucidate the molecular basis of MAO's activity, hoping that 
some understanding can be distilled from an extensive and 
conflicting research history, 
I would like to acknowledge the help offered to me by 
Dr, Gerry Young, Professor C. Norman Gillls and Mary Ellen 
Kavanaugh, Their concern was appreciated, their good spirits 
ind ispensible. For Donald Cohen, I have the pro found est •• v •• -: 
gratitude. For me, the most Important aspects of the past: 
year in research had little to do with laboratories and platelets 
as Donald well knows. Finally, I thank my wife for her love 
manifest in her endurance that supported me during this work. 

PHARMACOLOGY OF KAO 
Neuropsychiatric interest in Monoamine Oxidase (MO, 
EC 1,4.3.4.) was stimulated by several major findings in 
the 1950’s. Zeller discovered that iproniazid, an anti** 
tuberculosis agent, was a potent in vitro and In vivo 
inhibitor of MO. During the same period, Amin, Vogt and 
Bertler found that Serotonin (5-HT), Norepinephrine (NE), 
and Dopamine (DA), all substrates for MAO, were distlbuted 
in the brain. 
Clinically it had been noted that tuberculous patients 
treated with iproniazid experienced a lightening of their 
mood. This observation led Loomer and Saunders to.introduce 
iproniazid for the treatment of depression. Thus the 
groundwork was laid for the "catecholamine hypothesis" of 
affective disorders postulated by Schildkraut and Kety in 
1965. 
During the 1960"s, the investigation of KAO inhibitors 
was remarkable for the repeated finding that the substrate 
could influence the activity of the Inhibitor. Differences 
in inhibition kinetics, pH optima, Michaelis constants, 
ion effects and substrate inhibition suggested the presence 
of either multiple enzymes or one enzyme with multiple 
catalytic sites. Since all the work was done with reversible 
Inhibitors on non-purifled enzyme preparations, it was not 
possible to rule out steric factors as an explanation, 
in addition, no Inhibitor was found to selectively inhibit 
KAO activity to one substrate and not another.(for review, 
see Achee, Gabay and Tipton, 1977; Youdlm & Collins, 1975) 

(2) 
Johnston, In 1968, Introduced clorgyline as an irrever¬ 
sible inhibitor of MAO prepared from rat brain (Johnston, 
1968). The concentration of drug required to inhibit the 
oxidation of 5~HT was several orders of magnitude less 
than that necessary to inhibit benzylamine (BZ) oxidation. 
Of most significance was the effect of clorgyline on 
tyramine (TYR) oxidation. Only about half of the MAO activity 
toward TYR was Inhibited by clorgyline concentrations Com-- 
jpl&teiy Inhibitory of 5-HT oxidation. The rest was inhibited 
at concentrations necessary to stop BZ oxidation. This 
bi-phasic dose-response curve, with a plateau at medium 
inhibitor concentrations (Fig, 1), led Johnston to postulate 
the presence of two distinct enzyme species. One clorgyline 
sensitive and the other clorgyline resistant, designated 
Type A and Type B respectively. 5"HT was the preferred 
substrate for Type A and BZ preferred for Type B (Hall, Logan 
& Parsons, 1969)» with TYR a common substrate. 
Fig. 1 
(Fowler, et. al., 1978) 
o- 5-HT 
a- TYR 
9 - BZ 

(3) 
Since Johnston's report, other irreversible inhibitors 
have been introduced. Some have characteristics resembling 
clorgyline, while others selectively inhibit Type B MAO. 
Most notable of the later are Deprenyl (Knoll & Magyar,1972) 
and Pargyline (Puller, 1970). 
Johnston's work serves as the paradigm for studying the 
selectivity of MAO inhibitors and the proportions of MAO 
types in various organs from various species, always 
extrapolating from data on rat brain and liver. Selectivity 
experiments are performed assuming 5-HT oxidation to be 
exclusively by Type A and BZ oxidation by Type B, If an 
inhibitor shows concentration differences In its inhibition 
of 5-HT versus BZ oxidation, it is assigned a Type A or B 
selectivity depending upon which substrate is Inhibited 
by the lower concentration. Many of the reports on the 
selectivity of reversible inhibitors have used a single 
concentration of several substrates against a single con¬ 
centration of inhibitor. A difference in "% inhibition" 
is purported to suggest selectivity. However the differing 
Km values of the substrate could account for these results. 
Consequently, to effectively suggest selectivity of 
reversible inhibitors, it is necessary to compare Inhibition 
of substrates: at concentrations that are equal percentages 
of their Km's. Conclusive evidence for selectivity requires 
a full kinetic study determining both the type of inhibition 

(4) 
and the Kj_ value (i.e. concentration of inhibitor at which 
enzyme activity is reduced by 50$ ), (Houslay, Tipton & 
Youdim, 1976) 
In studying the properties of MAO from different organs 
and species, the assumption is often made that they will 
be similar to rat brain and liver in substrate specificity, 
differing only in the relatlvepproportion of Type A to B. 
A "biphasic" or "double-sigmoidal" curve of $ RAO activity 
to a common substrate like TYR versus Inhibitor concentra¬ 
tion implies substrate oxidation by two enzyme forms. The 
relative proportion of Type A to B is assessed by estimating 
the height of the plateau joining the sigmoidal parts of 
the curve. 
Much recent work base suggested that the simple binary 
classification Of RAO extrapolated from rat studies may 
not be universally applicable. For example, ox heart studies 
show a biphasic inhibition of 5”HT, suggesting that 5~HT 
is a substrate for both types. (Mantle, et. al., 1976). 
Pig brain MAO is reported to be Type B, but it is active 
toward 5“HT (Squires, 1972j Tipton & Spires, 1968). Lyle 
and Callingham haveshown that the apparent biphasic effect 
of clorgyllne to BZ oxidation in the rat heart is due to 
contamination by a connective tissue or blood vessel 
amine oxidase differing from MAO,(Lyle & Callingham,1975). 
This points to a disadvantage in using simple tissue 
homogenization for MAO preparation. 

(5) 
Substrate and inhibitor specificity can best be studied 
in terms of kinetic parameters. Supersaturating levels 
of substrates are frequently used in studying MAO proper- 
ties. If a so-called Type A substrate is oxidized, it Is 
assumed that Type A must be present. In fact, Type B has 
been found to metabolize Type A substrates and vice versa 
(for review, Fowler, et, al., 1978). Substrate specificity 
is best determined by comparing Km's and reaction velo - 
cities at substrate concentrations at equal percentages 
of their Km (Jain, Sands & Von Korff, 1973). 
Ekstedt studied the specificities of Type A and Type B 
MAO prepared from intact rat liver mitochondria. Type A 
substrates (5“HT and NE), Type B substrates (BZ and 
2-phenylethylamine, PEA) and common substrates (TYR and 
Tryptaraine, TRYP) were used in mixed-substrate experiments. 
In addition, the B form was selectively studied by inhibiting 
the A form with clorgyllne, and the A form studied by using 
deprenyl to inhibit the B form,(Ekstedt, 1976). 
Mixed-substrat experiments in uninhibited mitochondria 
showed that all six substrates inhibited activity to radio- 
labelled 5-HT to the same extent. This Implies that the Km 
of each substrate to the A form are equivalent. The substrates 
inhibited the activity to radiolabeiled PEA, though not to 
the same extent. This suggests differences in the Km of 
each substrate to Type B MAO. 

(6) 
Lineweaver“Burke plots performed on deprenyl-treated 
and clorgyline-treated mitochondria revealed competitive 
inhibition of all substrates for both A and B MAO, 
Deprenyl-treated mitochondria still retained 4# of acti- 
vity to PEA that could be inhibited by low concentrations 
of clorgyllne, Similarly, the 2% activity to 5~HT remaining 
after clorgyllne treatment was Inhibited by low concen¬ 
trations of deprenyl. Thus, 5~HT can be oxidized by Type B 
MAO and PEA can be oxidized by Type A MAO. The Km of 5"HT 
for MAO A was 6::x 10"*^ M versus 2.5 x 10™^ for MAO B. 
Interestingly, the Kffl iof PEA for MAO A was also 6,2 x 10 » 
the same as 5-HT, but PEA's Km for MAO B was 4 x 10 ° M. 
Substrate specificity is affected solely by the differing 
affinities of the two substrates for MAO B, 
It has been found that high concentrations of either 
clorgyllne or deprenyl will give 100# inhibition of both 
MO A and MO B, (Neff & Yang, 1974), Hence, substrate and 
inhibitor specificity, though significant at physiological 
concentrations, will be obscured by experiments performed 
at pharmacological levels, 
Jain has criticized the use of irreversible selective 
inhibitors as supporting evidence for multiple enzyme 
forms (Jain, 1977), Pointing out that pargyline, deprenyl 
and clorgyllne all Inhibit MO by stoichiometric binding 
to the FAD prosthetic group (Edmondson & Singer, 1976), 
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the multiple form hypothesis based on differential inact¬ 
ivation would require some other molecular basis other 
than similarity of binding to the flavin moiety. 
Tipton showed that at high clorgyline concentrations, 
rat liver MO was inhibited to 5-HT, BZ,and TYR, However, 
inhibition of 5~HT oxidation was more rapid than BZ, TYR 
oxidation inhibition occurred in two phases, corresponding 
to the fast and slow components for 5-HT and BZ respectively. 
Tipton concluded that clorgyline selectivity was caused 
by differing rates of attack (Tipton, 1971). 
Mantle, Wilson and Long introduced a new compound, PCO, 
with clorgyline“like inhibitor characteristics (Mantle, 
Wilson & Long, 1975a), In experiments using intact rat liver 
mitochondria, PCO inhibition was found to be time-dependent. 
After 45 minutes of preincubation, 5-HT inhibition was 
100$, with activity toward TYR only reduced 50$, An hundred¬ 
fold increase In PCO concentration gave 50$ inhibition ri 
without preincubation. It was concluded that PCO differential 
sensitivity arises from different rates of attack at two 
centers of oxidation. The rate of attack against the 
PCO-sensitive site was 200 times faster than the attack 
at the insensitive site. Interestingly, PCO was a compe¬ 
titive! inhibitor of TYR oxidation with hyperbolic kinetics. 
Hyperbolic competitive kinetics suggests competitive inhi¬ 
bition at two sites by an inhibitor with different affinities 
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for the two enzyme sites (Mantle, V/ilson & Long, 1975b). 
Still, these experiments cannot discriminate between one 
enzyme with different environments, two distinct enzymes, 
or one enzyme with two sites. 
The time-dependent, inhibition by clorgyline was further 
investigated by Lyles and Greenawalt. Many of the experi¬ 
ments studying the pharmacologically separable forms of MAO 
use preincubation periods differing from author to author. 
This could alter the characteristics of reported enzyme 
sensitivity. Using intact rat liver mitochondria the effects 
of preincubation time and enzyme concentration were studied 
(Lyles & Greenawalt, 1977). 
For 5-HT, time-dependent inhibition was observed only 
with clorgyline concentrations equal to 2 x 10 M and 
low enzyme amounts. At clorgyline concentrations greater 
-7 
than 2 x 10 M, only the second half of the biphasic 
curve to TYR oxidation was affected by preincubation. It 
seemed that only MAO B was sensitive , an observation 
confirmed by preincubation effects at all inhibitor con- 
centrations against BZ oxidation. 
The experiments point out that some molecular basis 
defining the rate of attack at a catalytic site » regardless 
of the final mechanism of MAO Inactivation at the flavin 
moiety, does exist. Careful attention to pre-incubation 
time, assay duration and protein content must be paid when 

C1 
comparing data from inhibitor studies of MO, 
Lineweaver-Burke plots of substrates in the presence.of 
varying concentrations of inhibitor permit classification 
of inhibition kinetics. Changes in the slope, intercept 
or both, reflect competitive, uncompetitive and non¬ 
competitive (mixed) inhibition respectively. Mantle, at, «1, 
showed that multiple-substrate experiments with 5-HT, NE, 
DA5 TYR, TRYP, BZ, PEA all resulted in competitive kinetics 
for rat liver (Mantle, Wilson & Lons?, 1975’°). 
Substrate competition experiments can be an effective 
technique for studying the relationship between differing 
enzyme activities. If two substrates are metabolized at 
the same active site, they will be competitive inhibitors 
of each other. When two active sites are present with 
exclusive specificity, the presence of one substrate 
should have no effect on the activity toward the other. 
By setting the concentration of one substrate at its 
Km, and the Inhibiting substrate at twice its K , the 
inhibition should be 50% if the substrates compete for 
the same site, and no inhibition if independent sites are 
involved. If two substrates share the same site, the Kj 
of a substrate should equal its Km» Under these conditions, 
using adult human brain and liver MO of intact mitochondrla, 
White and Wu found that 5“HT and PEA do not inhibit MAO 
activity to each other. This indicates that these substrates 

io 
are catalyzed by independent sites. Experiments with other 
substrates were not as elearcut (White & Wu, 1975). 
The interpretation of data derived under the conditions 
of these experiments requires certain assumptions that 
may not be appropriate. If either substrate is metabolized 
by additional active sites, the per cent inhibition will 
depend on the affinity and specific activity of the other 
sites. Another requirement Is that allosteric chancres of 
multiple enzyme forms do not occur. Finally, the experi¬ 
mentally derived K values used for ad justing substrate 
concentrations could be the average of the affinities for 
multiple active sites* This has been shown to be true for 
rat liver mitochondria (Ekstedt, 1976? Mantle, Wilson & 
Long, 1975^). 
Competitive kinetics can be classified into linear 
and non-linear types by replotting the slopes derived from 
Lineweaver-Burke plots against inhibitor concentration 
(Piszklewicz, 1977), The slope of such replots reflects 
the effect of an inhibitor at an active site. Replots that 
are linear signify either that there is competition at 
only one site, or that multiple sites are independent and 
are kinetically equivalent for substrate and inhibitor. 
Non-linear replots signify competition at multiple sites 
or allosteric effects on a single site. They are designated 
either hyperbolic, with a convex-upward curve, or parabolic, 
with a concave-upward curve. 

/ / 
By extrapolating the initial and final slopes of non¬ 
linear replots to the inhibitor concentration axis (abscissa), 
two apparent K.’ s reflecting high and low modes of inhibitor 
binding are obtained, Hyperbolic plots show high affinity 
binding at low Inhibitor concentrations, while parabolic 
plots show high affinity binding at high inhibitor concen¬ 
trations. (Fig, 2) 
Computer simulation of the competitive inhibition of 
two independent active sites kinetlcally similar for the 
substrate but with two differing affinities for the inhib¬ 
itor yields hyperbolic kinetics (Mantle, Wilson & Long, t 
1975^)* Parabolic replots cannot be derived from such a 
model, and are evidence for an Interacting site model of 
enzyme activity. 
In all mixed-substrate experiments that show competi¬ 
tive inhibition, the inhibition Is in effect a dilution 
of the labelled product of the substrate by the unlabelled 
products of the competitive inhibitor. This can be shown 
by double-label experiments. Consequently, the is 
equivalent to the of the inhibitor at an active site. 
The fit between experimentally derived Km*s and K^'s for 
substrates and their correlation to computer derived 
kinetic parameters will differentiate between hyperbolic 




Mantle, Wilson and Long found linear kinetics for all 
substrates versus 5~HT oxidation suggesting one site of 
MO activity for 5“HT. Linear replots we re obtained for u 
most substrate interactions. However, 5~HT was found to 
inhibit the "common substrates" DA and TYR by hyperbolic 
kinetics. The good correlations between K 's and K^*s 
experimentally, and to simulated plots point to the 
existence of two independent active sites for MO oxida¬ 
tion (Mantle, Wilson & Long, 1975"b). This is in agreement 
with work on rat liver showing two Km9s for 5-HT differing 




Fig. 2. Computer simulation of hyperbolic slope replot 
for competitive inhibition of 2 klnetically equivalent 
sites for substrate by an inhibitor with different 
affinities (K^ = high affinity; K^= low affinity) for 
two Independent sites. Dotted lines represent extrapola¬ 




The heterogeneity of MO activity revealed by pharmaco¬ 
logical studies prompted the implementation of elec¬ 
trophoretic techniques for elucidating the structural 
basis of this behavior. 
In 1967, Youdim and Sandler used polyacrylamide gel 
electrophoresis to separate different constituents of 
solubilized MAO from rat liver and human placenta (Youdim 
& Sandler, 1967), Soon after, Kira and D’lorio used cellulose 
acetate electrophoresis to describe multiple bands of MO 
activity from rat liver homogenates. In addition, they 
reported similar results when solubilization by detergent 
was compared to sonlcation (Kim & D’lorio, 1968). Kim and 
D’lorio were not willing to preclude either incomplete 
solubilization or enzyme association with subparticles of 
membrane debris as explanations for the multiple bands. 
Youdim followed his initial work with experiments to 
characterize the properties of the electrophoretic bands. 
Briefly summarized, it was found that K *s for substrates 
were similar* yet the V 's were not. The bands showed 
max 
differing inhibitor sensitivities, differing pH optima 
for maximal kynuramine (KYN) oxidation, and differing 
susceptibility to heat inactivation:(Youdim, Collins & 
Sandler, 1970). The results were similar for both rat liver 
and brain (Collins, Sandler, Williams & Youdim, 1970). 
The molecular weights (MW) of the bands were equivalent, 
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290,000-320,000, by gel filtration. With ultracentrifu¬ 
gation, the bands had a MW= 150,000 (Youdlm &_ Collins, 1971). 
The denaturation of partially purified rat liver MO 
with 8M urea or 1% sodium dodecyl sulfate (SDS) yielded 
a single band upon electrophoresis. The band had 100% loss 
of activity, and a molecular weight of 78,000. Reassociation 
by dialysis resulted in 5 bands on electrophoresis, similar 
to the non-denatured preparation. When each Isolated band 
of activity was subjected to denaturation, a single band 
of MW- 76,000 migrated identical to the band of denatured 
whole enzyme preparation. However, upon reassociation 
and electrophoresis, each original band of activity resulted 
in 5 bands with a pattern identical to the denatured- 
reassociated whole enzyme preparation (Youdlm & Collins, 
1971). 
Youdlm and Collins interpreted their results as revealing 
an MAO consisting of inactive subunits of MW = ?8,000.‘ 
they concluded that MAO could not be an enzyme of MW ~ 150,000 
with two sub-units, nor an enzyme with four sub-units and 
a MV/ = 300,000. They only entertained the possibility of 
two dissimilar sub-units, one with a substrate binding 
site (Ss), and one without (S). Thus, an enzyme with two 
sub-units would permit only two active forms (SsS and 2Ss), 
and an enzyme with four sub-units would give only four 
active forms (4Ss, 3SsS, 2Ss2S, Ss3S). Neither model gives 
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the five active forms achieved by electrophoresis. Instead 
the authors felt the five active forms could represent 
conformational enzymes, differing only in tertiary struc¬ 
ture. This would also also explain how the denaturatlon- 
reassoeiation of each individual form could yield all five 
forms (Youdim Sc Collins, 1971). It should be noted that 
the authors assumed that the five forms are not artefacts 
of their solubilization procedure. Nor did they entertain 
other models of sub-unit interaction in an enzyme. For 
example, two inactive sub-units of MW ™ 75»000 may be 
necessary to bind with the FAD cofacter to yield an active 
enzyme with MW ~ 150,000. 
Sierens and D'lorlo pointed out the problems inherent 
in the harsh solubilization techniques. Using the ionic 
detergent deoxycholate and gel electrophoresis, they were 
able to separate two fractions of MO activity from rat 
liver mitochondria (Sierens & D’lorio, 1970), One fraction 
acted on BZ and 5“HT, the other on BZ alone. However, 
compared to untreated mitochondria, both fractions had 
reduced activity. MAO activity to 5“HT was only 2% and to 
BZ but 20^ in the first fraction. Further experimentation 
showed that dialysis partially prevented the loss of acti¬ 
vity, Deoxycholate bound to enzyme could not explain the 
results as it did not migrate with either fraction. 
The authors concluded that the apparant MO multiplicity 

was likely secondary to Irreversible damage to 5~HT activity, 
and not to KAO Isoenzymes differing in protein constitution. 
This experiment pointed out both the need for a solubili¬ 
zation method that causes only a minor reduction in activity 
as tested against several substrates, and that chromato¬ 
graphic or electrophoretic separations alone are not 
sufficient for establishing enzyme multiplicity. 
In later work, Diaz, Sierens and D’lorio were able to 
partially separate 5~HT activity from BZ activity using 
density grad lent electrophoresis and sonication with only 
a 20-25/e reduction of MAO activity to BZ, 5‘a,HT and KYN. 
The results were suggestive of at least two different 
activities, though the data could not distinguish between 
two enzymes, multiple forms of one enzyme, or association 
of enzyme with non-protein molecules (Diaz-Borges & D’Xorio, 
1972) 
Oreland and Olivecrona studied the binding of KAO to 
mitochondria and found that the liberation of soluble MAO 
enzyme correlated with the extraction of cardlolipin, an 
anionic phospholipid. Using purified phospholipids, they 
found soluble complexes of MAO and cardiollpin, or insoluble 
complexes if the cardiollpin were bound to delipldated 
mitochondrial membrane residues (Oreland & Olivecrona, 1971j 
Olivecrona & Oreland, 1971). ' 
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Tipton explored the relationship between separate 
activities of MAO and bound membrane material by measuring 
the phospholipid content of electrophoretically separable 
forms of MAO (Tipton* 1972), Phospholipid content and 
mobility were Inversely related, with the fastest moving 
band having the lowest amount of phospholipid, Reasoning, 
that if lipids were responsible for apparant isoenzymes, 
then the distribution of electrophoretic forms should be 
affected by techniques that extract lipids. Organic solvents 
caused a significant loss of activity, but the non“ionic 
detergent Triton X-100 yielded only a single band with 
mobility similar to the fastest moving band. 
Tipton stated that Triton X-100 had no effect on MAO 
activity to BZ, 5~H?» DA or TYR, using purified rat liver 
MAO. He did not report his results, and it is difficult 
to rule out the possibility of damage to one enzyme form 
that could be obscured by measuring activity against a 
non-separated preparation. 
Tipton did find that prolonged dialysis against Triton 
X-100 or Phospholipase A resulted in the loss of MAO acti¬ 
vity, though a single band was still observed. This raised 
the possibility that lipid is vital to the stability of 
MAO, and that the loss of electrophoretic heterogeneity 
could result from the denaturation of active forms. 
Oreland showed that 1.5% Triton X-100 for three hours 

did not affect the K of BZ, compared to a mitochondrial 
Xu 
preparation (l.e. enzyme in situ) of pig liver M0» but 
the Vmax was reduced , in agreement with Tipton. 
To circumvent the methodological issue raised by 
detergent' binding'to enzyme, Oreland used an organic 
solvent and salt solubilization-purificatIon procedure 
with a yield of 20% MO activity. Both the K and V 
were lowered for BZ, corroborating the influential role 
played by lipids (Oreland, 1972). 
Oreland did not feel that his extraction procedure may 
have preferentially lost one of the isoenzymes, though 
it could account for the change in Michaelis parameters 
versus the enzyme in situ. For example, the loss of a form 
with a higher Km for BZ that signifIcantly contributes to 
BZ oxidation at the BZ concentration used, could appear 
as a decrease of Km and Vmax. 
Oreland concluded this was not the case because the 
percentage activities to various substrates versus activity 
to TYR were not signifIcantly changed. Such experiments are 
carried out at a single substrate concentration signifi¬ 
cantly higher than its to ensure enzyme saturation. 
The activity recorded is then considered the V . 
Consequently, the loss of one form would be observed only 
if it were responsible for a significant portion of enzyme 
activity at that substrate concentration. 

Pharmacological experiments with pig liver found 
only the B form, so Oreland's work is not conclusive 
(Squires, 1972). In later experiments with rat liver, 
Oreland discovered the preferential loss of Type A 
activity with retention of the B form (Ekstedt & Oreland, 
1975). 
Houslay and Tipton continued the Investigation of i. >3 
protein-membrane interactions and rat liver MAO by using 
sodium perchlorate, a chaotropic agent. These compounds 
are capable of weakening hydrophobic bonds between proteins 
and lipids, thus disrupting protein-membrane complexes. 
Polyacrylamide gel electrophoresis x-zas used to compare 
a perchlorate-treated solubilized enzyme preparation, an 
untreated solubilized enzyme preparation, and a mitochon¬ 
drial outer membrane preparation that contained 90)? of 
enzyme activity. Both the outer membrane preparation 
representing KAO in situ, and the perchlorate-treated• 
enzyme showed one band of activity migrating similar to 
the slowest moving band of the untreated enzyme. In 
addition, one band of activity originally described by 
Youdim was found to be an artifact of the gel loading 
procedure, 
Sodium perchlorate treatment caused no loss of activity 
for incubation periods up to ten minutes. There was no 
difference in the Km or Vmax for BZ, TYR or DA, suggesting 
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that perchlorate treatment did not alter the active site 
of the enzyme. All substrate“related differences in heat 
inactivation, pH optima, and inhibitor effects of harmine, 
phenylethylhydrazine and clorgyline were abolished by 
perchlorate treatment (Houslay & Tipton, 1973). 
Houslay and Tipton concluded that the apparant electro¬ 
phoretic heterogeneity and substrate specific activities 
of MAO were probably secondary to the solubilization proce¬ 
dure. The electrophoretic heterogeneity did not exist In 
the mitochondrial outer membrane preparation, though none 
of the other parameters of heterogeneity were tested. They 
speculated that the vigorous sonlcation-detergent steps 
could result in unknown complexes of membrane lipid, enzyme 
and Triton X-100 causing apparant multiple forms. 
It is not possible to categorically deny the existence 
of multiple forms since the solubilized enzyme preparation 
retained less than 50% of the original activity. In this 
context, it should be recognized that Houslay and Tipton 
used 2% Triton X-100, previously found to inactivate MAO 
(Tipton, 1972; Oreland, 1972), and 50 mM Trls buffer, a 
reversible non-competitive inhibitor of TYR, 5“HT and 
PEA oxidation with a of 15 "25 mM (Fowler, Callingham 
& Houslay, 1977). BZ Is not inhibited by Tris, Consequently, 
all experiments exploring substrate-spec ificity are most 
difficult to interpret. 
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Singer has warned that all chaotropic agents affect 
protein structure. While catalytic and inhibitory prropertles 
may be intact, the more subtle and significant in vivo 
regulatory properties can be modified (Singer, 1976). 
Jain and Sands reviewed the literature on electropho¬ 
retic heterogeneity and found that all such reports used 
extended periods of sonication for their enzyme preparations. 
By using a non-sonication procedure for solubilization of 
human brain MAO, they found only a single band of activity 
on polyacrylamide gel electrophoresis. In addition, the 
Mlchaelis constants for this purified enzyme were very 
similar to those of an intact mitochondrial enzyme prepa¬ 
ration. Thus Jain and Sands added evidence to the artefact 
theory of MAO electrophoretic multiplicity, implicating 
sonication (Jain and Sands, 197^). 
The non-sonication procedure used by Jain and Sands was 
originally developed by McCauley and Racker. This purifi¬ 
cation used lOOmM Tris and 1.5% Triton X-100 (McCauley & 
Racker, 1973). The Mlchaelis constants were derived from 
a solution of 100 mM potassium phosphate buffer, a 
significant inhibitor of MAO (Jain, Sands & Von Korff, 19735 
Van Woert & Cotzias, 1966). These constants were very 
similar to those reported for the B form of human brain 
MAO (White & Glassman, 1977). 
Sonication does not invariably lead to electrophoretic 
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heterogeneity, as studies on the human platelet have 
revealed (Collins & Sandler, 1971). Sandler and Youdim 
contended that sonicationwould have been expected to give 
an infinite gradation of membrane particles rather than 
the reproducible bands (Sandler & Youdim, 1972). It has 
been pointed out that specific sites in the protein structure 
may exist at which it will preferentially split or dissoci¬ 
ate under the stress of sonicatlon or solubilization 
(Jain, 1977). 
All of the work referred to above on multiple bands of 
MAO activity used a colourimetric technique for localizing 
MAO activity with nitroblue tetrazollum reduction by MAO 
as the marker. However, some MAO substrates themselves 
can reduce tetrazollum (NTZ) salts (Lagnado & Sourkes,1958), 
and NTZ strongly inhibits MAO activity as compared to 
radioassay techniques (Lagnado, Okamoto & Youdim, 1971). 
It is also possible that one of the enzyme forms is not 
MAO, though It can oxidize monoamines to give electrons 
to NTZ yielding a positive reaction (Guha & Ghosh, 1970). 
The existence of such an enzyme with activity toward 
TRYP and inhibited by iproniazid has been detected in the 
brain of rats (Ghosh & Guha, 1978). 
Diaz-Borges and D’lorlo used the non-ionic detergent 
12.5# Lubrol and sonicatlon to prepare rat liver MAO and 
0.4# Lubrol in solutions for polyacrylamide gel • 
a ’ 

electrophoresis (Diaz-Borges & D'lorio, 1973). Using a 
radioassay, they achieved a complete separation of BZ 
and 5-HT activity with overlapping activity toward TYR. 
Upon comparing the radioassay to NTZ staining, little 
correlation was seen. 5-HT, TYR or TRYP in the staining 
mixture gave a broad purple band that was abolished by 
pre-incubation with the MAO inhibitor isocarboxid. No such 
band was observed with BZ as the substrate. Staining of 
the gels with BZ, TYR or TRYP gave a yellowish-purple 
backround with soma zones lighter or darker, giving the 
appearance of bands. However, isocarboxid pretreatment • 
failed to abolish this effect, suggesting it was not due 
to MAO activity. 
These experiments point out the inadequacies of colour- 
imetric staining for detection of MO activity. They'are 
remarkable for the total independence of electrophoretic 
mobility of 3Z and 5-HT activity, analogous to Johnston's 
mod el. 
The solubilization technique used had previously been 
shown to give 83$ recovery of BZ activity and 79$ recovery 
of 5-HT activity, so the possibility of selective degra¬ 
dation of one form is less likely (Diaz-Borges & D'lorio, 
1972). Experiments on the separate activities assessing 
phospholipid content, MW, activity after chaotropic 
treatment, and pharmacologic, immunologic and kinetic 
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characterlstics are necessary to establish the existence 
of two distinct enzyme proteins, 
Inoue, Robinson and Dost compared radioassay and colour!- 
metric assays using rat liver and brain prepared according 
to Youdlra in 1.5% Triton X~100. Additionally, the prepara¬ 
tion was dialyzed against phosphate buffer for over 60 hours 
to remove the Triton X-100 (Inoue, Robinson & Dost, 1976), 
Where four bands were found on gel electrophoresis with 
NTZ, only one band (corresponding to the least mobile one 
1 h 
with NTZ) had activity with a C" “-labelled substrate. The 
results were the same using radiolabelled BZ, TRY? or TYR. 
Consequently, the Triton X-100 per se does not cause the 
heterogeneity observed by Youdira, though all work using 
NTZ must still be viewed with caution. 

MOLECULAR WEIGHT OF MAO 
The molecular weight of MAO has been studied to 
elucidate the nature of the multiple activities. In 
general, the MV/ has been measured by various investigators 
with little agreement. Only If the molecular weight is 
calculated per mole of flavin, the enzyme co-factor, is 
there agreement - 1,2 - 1.5 x 10^ g mao per mole of 
Qc< ~ (cysteinyl)FAD (Sandler & Youdim, 1972), 
Youdim and Collins, using a 1,5$ Triton X-100 prepa¬ 
ration of rat liver MAO found a MW = 300,000 for both 
whole enzyme and Its electrophoretically separated forms 
using Sephadex gel filtration. However, ultracentrifuga¬ 
tion gave a MW = 150,000. 8 M urea or 1% SDS yielded 
inactive sub-units with MW = 75,000 by gel filtration. 
By using phenelzine, an irreversible MAO inhibitor that 
binds to the flavin moiety, Youdim found a molar ratio of 
Phenelzine / FAD / 150,000 MW (Youdim & Collins, 1971). 
Orelandf using a ketone extraction method, obtained a 
purified MAO with a strong tendency to aggregate. A series 
of gel filtrations on Sephadex G-200 with increasing 
concentrations of the ionic detergent sodium cholate, gave 
a MW - 290,000 for enzyme still active to BZ in 2.5$ 
cholate. 10$ cholate showed two peaks of activity, one 
at 290,000 and another at 115,000. When the enzyme of 
MW - 115,000 was rechromotographed without cholate, It 
aggregated and appeared in the void volume. Using pargyline, 

Oreland found a molar ratio of 1 ; 1 : 1 of pargylino/ 
flavin/ protein of MW ” 115»000 (Oreland, 1972). Oreland 
Interpreted these results to suggest protein aggregation 
as the basis for electrophoretic heterogeneity. An 
alternative interpretation is that the sodium cholate 
may have affected the retention on the column, giving 
falsely decreased estimations of MW. 
Shih and Eiduson solubilized rat brain MAO in Triton 
X-100 and used both agarose and Sephadex electrophoresis 
to separate MAO. Agarose separation yielded two fractions, 
A s.nd B (not to be confused with Johnston’s pharmacological 
6 designations) with MW=1.5-10 d and 500,000 respectively. 
To investigate the question of aggregation, the MAO was 
reehromotographed in the presence of 8M urea, speculating 
that A would disappear, with a concomitant Increase in B. 
In fact, soma of A did disappear, but all of B seemed to 
disaggregate to a fraction C with a smaller MV/. All 
fractions were active to 5~HT, BZ, TRYJ? and PEA. Rechroma¬ 
tography of B alone showed partial reaggregation to A. 
Further, when low concentrations of enzyme preparation 
were added to the agarose column, some of A and all of B 
converted to C, Sephadex G-200 chromatography yielded 
analogous results. 
In general the specific activity to substrates increased 
with separation, i.e. C>B)A, though the change was not 
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consistent through the steps. This differential increase 
in specific activity was interpreted as evidence for forms 
of MAO that differ in teh aggregation of sub-units (Shih 
& Eiduson, 1974). 
Experiments by Inoue, Robinson and Dost suggest another 
explanation, Noting the wide use of Triton X-100 in 
solubilization procedures, they pointed out that dialysis 
to remove the detergent from the partially purified enzyme 
is rarely carried out (Xnoue, Robinson & Dost, 1976). 
If dialysis were for less than 60 hours for rat liver 
and brain MAO, a significant amount of MAO activity was 
held up on Sephadex G-200, Most came off in the void 
volume, in agreement with Oreland and Shih and Eidus on. 
The portion held up corresponded to Fraction B. Dialysis 
for longer than 60 hours showed a single peak of activity 
appearing in the void volume, 
Inoue felt this phenomenon could be due to the high 
affinity of the protein to the Triton X-100 with stabili¬ 
zation of the enzyme in a disaggregated form. As little as 
0.3$ Triton X-100 added to enzyme dialyzed for 60 hours 
and already passed through the column, caused the complete 
retardation of enzyme activity on Sephadex G-200. Consequently, 
variable gel filtration behavior used to show multiple 
forms and to determine the MW can be partially attributed 
to differing amounts of detergent remaining in the enzyme. 

IMMUN0LOGICAL APPR0ACHES 
The controversy over multiple forms led some investi¬ 
gators to employ immunological techniques in the investi¬ 
gation of enzyme heterogeneity. In general, the degree of 
structural-relatedness of MAO forms was studied using 
antigen-antibody cross-reactivity in double diffusion 
experiments. 
Hartmann and Udenfrlend used bovine liver separated int 
three fractions with MAO activity (Hartmann & Udenfrlend, 
1972).Two of the forms were pure protein, designated 
C^ with MU-400,000 and 4 moles FAD per mole, and C^ with 
MW=1,200,000 and 12 moles FAD per mole. The third form 
was a protein fraction contaminated by other proteins 
and residual Triton X-100, designated Fraction A. 
Antibodies were induced against C2 because it would 
presumably contain the most antigenic sites with some 
differing from C^ and Fraction A. Immunodiffusion yielded 
single precipitin lines without spurs, suggesting both 
antigenic identity and the absence of sites on C2 not 
found on the other forms. The impurity of Fraction A 
left the possibility of an MAO antigenically distinct from 
C . Immunoprecipitin titration resulted in the total 
removal of MAO activity from Fraction A, ruling out the 
presence of a structurally unrelated form. 
C2 antibody tested against a crude Triton X-100 solubi¬ 
lized liver MAO gave 93$ removal of MAO activity. The 
preparation retained only 65$ of total liver MAO activity 
to BZ, so the possibility of a denatured form exists. 

Cross-reacting C£ antibody to bovine brain MO left 
immunoprecipitin lines of identity without spurs. Yet, 
immunotitration could precipitate only 80/6 of brain MO 
activity to BZ'. The remaining 20% was felt to represent 
a "brain-specific MO" antigenically distinct. 
It would be Interesting to explore these immunologlcally 
separable forms with other substrates and inhibitors using 
proper kinetic techniques, and to see if antibody to the 
"brain-specific MAO" could be induced. 
McCauley and Racker extended the work on bovine brain 
and liver MAG antigenicity, though their antigen preparation 
differred from Eartmann and Udenfriend (McCauley & Racker, 
1973). They added the use of selective Inhibitors and 
more substrates to characterize brain MAO activity not 
preclpltable by antibody Indue cc'i* gainst liver MAO. 
Essentially, they found that non-precipltable MO had 
activity to 5~HT and NE much greater than its activity to 
BZ. Precipitable MO had no activity to 5“HT or NE, while 
retaining significant activity to BZ. Both forms had activity 
to DA and TYR. The non-precipitable activity toward NE and 
5-HT was inhibited by harmaline, an MO A inhibitor, and 
resistant to pargyline inhibition. The precipitated MAO 
showed the reverse inhibitor sensitivity. 
These results are analogous to Johnston's model, so 
McCauley and Racker concluded that non-precipitable brain 
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MO was indeed Type A MO, a form antigenieally distinct 
from bovine liver MAO, designated Type B, 
Unfortunately, the authors did not attempt iramunotltra- 
tion or the addition of anti-globulin to the supernatant 
to rule out incomplete precipitation secondary to soluble 
antigen-antibody complexes. Therefore » it is still con¬ 
ceivable that the two pharmacologic types differ only in 
the number of similar sub-units. 
Dennick and Mayer prepared rat and human liver MAO 
specifically purified by prolonged t»5% Triton X-100 
incubation to electrophoretic homogeneity in the presence 
of SDS, Activity to 5™HT was completely lost, and only._ 
3% of total activity was retained,(Dennick & Mayer, 1977). 
Antibody induced from this MAO preparation was able to 
immunoprecipitate 100% of. the activity to 5~HT, BZ and 
TYR in liver mitochondrial extracts by equal n. volumes 
of anti-serum, Dennick and Mayer concluded that all liver 
MAO activity resides in one macromolecular species. 
This conclusion is legitimate only if the specificity 
for a substrate is absolute. The relative activities of 
the liver mitochondrial extracts suggest that MO A, with 
its activity toward 5-HT greater than its activity to BZ, 
was not present. Inhibitor studies of the mitochondrial 
extracts might have proven Illuminating. The extended 
Triton X-10Q treatment used in their preparation could 

31 
have preferentially denatured an A type MAO more dependent 
on lipid moieties for activity. 
Youdim has shown that SDS will yield a homogeneous protein 
from active multiple forms, that is inactive with a MW .one- 
half to one-quarter that of active MO. Consequently, 
Dennick and Mayer may have formed antibody to an inactivated 
I4.A0 A, though not antigenically destroyed. 
All the immunologic studies are equally consistent with 
a single enzyme modified by membrane-binding masking the 
antigenic response (Toozg, 1973)j or the presence of more 
than one enzyme. 

ONTOGENIC PATTERNS 
The ontogenesis of MAO has been studied in many organs 
of many species (for review, Gripols, 1975). Eiduson 
the rat brain, liver and heart using polyacrylamide gel 
electrophoresis and NTZ staining. He found differences 
between adult and neonatal rats in the number and position 
of bands, and that testosterone could affect the number 
of bands ( Eiduson, 1972), Blatchford, Holzbauer and 
Youdim found that the specific activity to TYR and DA 
increased with age in the hypothalamus and striatum of 
three rat strains. TRYP oxidation decreased in the hypo¬ 
thalamus and striatum from only two of the strains, 
suggesting age, species and substrate effects on the 
development of MAO activity (Blatchford, Holzbauer & Youdim, 
1975). 
Jourdikian attempted to classify maturational rates 
of Type A versus Type B MO in the mouse brain. Type A, 
identified by using 5~*HT as a substrate and clorgyline as 
an inhibitor, reached adult levels by 20 days old, when 
Type B was only 50% adult values (Jourdikian, Tabakoff & 
Alivisatos, 1975). 
In the rat, fetal liver has a fully developed binary 
system of MAO. However, fetal brain MAO was 97% Type A. 
It is not until Day 45 post-natally that the adult propor¬ 
tions of 60$ A : 30$ B is achieved (Mantle, Garrett & 
Tipton, 1976). Mantle speculated that Type A may represent 
a fetal form since it is the predominant type in glioma 
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and neuroblastoma (Donnelly, Richelson & Murphy, 1976). 
Using a different strain of rats, Bourgoin discovered 
adult levels of MO B by Day 20, while MAO A activity was 
80% higher in brain stem homogenates and 20$ higher in 
forebraln homogenates at Day 20 post~natally, as compared 
to adult rats. Kinetic analysis revealed a higher V_Q„ 
in neonatal rats with no difference in the K of 5“HT, 
implying greater amounts of enzyme in the pup. At birth, 
rat brain 5-Hydroxyindole acetic acid (5raHJAA) is equal 
to adult 5-HIAA, though 5“HT at birth is only 33% of 
adult levels (Bourgoin, et.al,, 197^* Bourgoin, et. al,, 
1977). Thus maturational changes In MAO activity are 
significant for the regulation of brain monoamines. 
Experiments in the ontogenesis of MAO have not discrimi¬ 
nated between changes with age of brain lipids, mitochondria 
or protein molecules. They do bring evidence pointing to 
the Importance of the distinction between MAO activities, 
each under different regulation. 
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MAO IN SITU - THE MITOCHONDRION 
The work of Schnaltman and Greenawalt has localized 
KAO to the outer membrane of the mitochondrion. The 
outer membrane (OH) can be dissociated from both the 
matrix (M) and inner mitochondrial membrane (IM) by 
dlgltonin treatment. The small vesicles formed from OK 
were found to have a greatly increased specific activity 
for MAO and represented a large fraction of the total 
mitochondrial MAO activity. The IM-M fraction, called 
mltoplasts, retain essentially no MAO activity (Greenawalt, 
1972). 
Mitochondrial membranes are dynamic structures with 
their components undergoing continuous turnover. The 
IM and OM proteins undergo independent, asynchronous 
synthesis (C-ear, 1970). 2.0% of mitochondrial protein is 
in the IM, 10% in the matrix, 6% as intermembrane protein, 
and only in the OM (Schnaltman & Greenawalt, 1968). 
as a result, changes in the ratio of IM to OM, or OM to 
mitochondrion could cause changes in the amount of enzyme 
activity per amount of protein. The IM s OM ratio in rat 
heart is 20 % 1, while in- liver it is 5 * 1. This could 
explain the relatively lower MAO activity of heart mito¬ 
chondria (Greenawalt, 1972). Differences in phospholipid 
to protein ratios and in the lipid composition of the two 




Thls intimate localization of MAO in the OM forms the 
basis for much of the dispute regarding enzyme multiplicity. 
Membrane“bound enzymes have a tendency to change charac¬ 
teristics upon solubilization and purification. These 
changes are referred to as allotopic properties, Houslay 
and Tipton found that solubilization of MAO causes a 
significant alteration in the kinetic mechanism. It 
implies the necessity for the enzyme to adopt a conformation 
normally dictated by the membrane environment (Houslay & 
Tipton, 1975)* Perchlorate treatment abolished the Diphasic 
inhibition pattern of both deprenyl (Tipton, Houslay & Mr 
Mantle, 1976) and clorgyline to TYR oxidation ( Houslay & 
Tipton, 1973). 
The mitochondrial environment could enforce specific 
conformations on one protein, preferentially stabilize 
one of several proteins, or expose different catalytic 
sites on one protein. Any of these alternatives would 
present multiple enzyme activities in vivo. 

The allotopic properties of-MAO suggest that the 
microenvironment plays a significant role in MAO activity, 
especially in creating a relatively non-polar environment 
to favor amine oxidation. Some investigators have studle 
MAO in purified intact mitochondria in an attempt to resolve 
inconsistencies and to elucidate the action of the enzyme 
in a more natural state, 
Gahay used a mitochondrial preparation from bovine brain 
with a fair degree of morphological integrity and freedom 
from contamination as assessed by electron microscopy and 
enzyme marker studies. This preparation had 80$ of the MAO 
activity found in brain homogenates (Gabay, Achee & Mentes, 
1976). 
Substrates were tested against pH, ions and thermostability, 
all expected to affect environmental conditions. Cationic 
species seemed to have no effect, but phenylalkylamines 
(PEA, TYR)were more affected by phosphate ions, and the 
lndolealkylamines 'were more susceptible to inhibition by 
chloride ions. Increased chloride gave non-competitive . .?. 
inhibition to the lndolealkylamines and mixed-competitive 
inhibition to the phenylalkylamines. This might indicate 
a difference in binding groups for the substrates within 
an active site, 
Gabay also reported differing pH optima for the Km and 




that the true substrate for MAO is the unprotonated amine 
(McEwen, et. al,, 1968; McEwen, et, al,, 19^9* Williams, 
1974), Upon correcting for the degree of ionization, 
Gabay found that the the optimal pH for the Michaelis 
cdnstants of the unionized amines was pH= 7,4, Finally, 
there was no difference in thermostability to any substrate 
in intact mitochondria, though this has been reported 
as evidence for the existence of multiple forms, 
Clorgyline and harmaline were found to be selective 
for 5-HT activity versus PEA, but dose-response curves 
were biphasic for all substrates. The Type B inhibitor 
deprenyl required pre-incubation to give substrate selecti¬ 
vity at low inhibitor concentrations. The difference 
stemmed from the slower rate of PEA inactivation. This 
was true for high clorgyline concentrations also. 
Mixed-inhibitor studies were most suggestive of two 
sites distinct for different inhibitors though not 
mutually exclusive for substrates. The combination of 
Type A and Type B inhibitor had additive effects to achieve 
total MAO inhibition, whereas two inhibitors of the same 
type gave only partial inactivation.(Achee & Gabay, 1977), 
Of Interest was the finding that 100$ inhibition of 
5-HT was never achieved by these authors, though activity 
to all other substrates could be totally abolished, 
Williams found 5-HT oxidizing activity localized in the 
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circumventricular structures of rat brain that is not 
inhibited by high elorgyline concentrations (Williams, 
Gascoigne & Williams, 1975). Though substrate and inhibitor 
studies have yet to be done, these results are clinically 
significant for the suggestion of an MO type Intimately 
associated with the hypothalamus and C3F distinct from ' • 
the activities normally studied. 
Improvement in subeellular fractionation using density 
and zonal centrifugation have led to the conclusion that 
mitochondrial populations are heterogenous. Differences in 
bouyant density and enzyme activity have been reported. In 
brain, it has been possible to separate neuronal and glial 
mitochondria, and synaptosomal and non-synaptosomal 
mitochondria (for review, Van den Berg,1973). 
The first report of mitochondrial heterogeneity of MO 
activity was by Kroon and Veldstra, using homogenization 
of rat brain In isotonic sucrose to separate out synap¬ 
tosomal mitochondria. Zonal centrifugation in sucrose 
density gradient gave a partial separation of synaptosomes 
and free mitochondria. The distribution of enzyme activities 
suggested that MAO activity to 5”HT and DA is localized in 
mitochondria differing from NE and KYN oxidizing MO, 
(Kroon & Veldstra, 1972). 
High sucrose densities cause marked mitochondrial and 
synaptosomal distortion through osmotic shifts, so Youdim 
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used an iso-osmotic Ficoll-sucrose gradient to prevent 
artefacts (Youdim, 197^). Rat brain and liver showed 
heterogeneity of MO activity to TYR, TRYP, KYN and DA, 
though no fraction had activity exclusive for any substrate. 
The MO activity as measured by Youdim and Kroon and 
Veldstra were using substrates at saturating concentratins. 
All of Youdim*s substrates are "common'’ as defined by 
Johnston pharmacologically. The heterogeneity could represent 
differences in the proportion of MAO A to MO B in the 
mitochondria. In this vein, Neff used sucrose density 
gradients and found two regions of activity to TYR, Using 
the ratio of PEA-MO activity to 5-HT-MO activity, it 
was found that mitochondria with higher bouyant density 
seemed to have MO B by virtue of its high PEA:5~HT 
oxidizing ratio (Neff, Yang & Puentes, 197*0. 
Owen used a Ficoll-sucrose discontinuous gradient to 
separate three populations of rat brain mitochondria. 
Two were derived from synaptosomes, and a third ostensibly 
non-synaptosomal and glial (Owen, et. al., 1977). The 
synaptosomal populations had equal specific activity to 
5-HT, but all three groups differed in specific activity 
to PEA, The heavy synaptosomal fraction (SM2) had greater 
PEA-MAO activity than the light (SMI) population. The free 
mitochondrial population had the lowest specific activity 
to both substrates. 
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Clorgyline and deprenyl gave biphaslc inhibition of 
TYR oxidation in all fractions. The plateaus suggested that 
SMI had a greater proportion of MAO A than did SM2, SMI, 
with the lowest PEA55“HT activity ratio was most susceptible 
to clorgyline and least sensitive to deprenyl. The reverse 
was true for the SM2 fraction. 
These findings were extended to mouse lung mitochondria 
separated Into a light population with low PEA; 5~HT activity 
ratio and a denser population with high PEAs5-HT activity 
ratio (Gallagher, 1977). When the mouse was pretreated 
with pargyline (MAO B inhibitor) before sacrifice, 5“HT 
MO activity remained high and peaked in the light mito¬ 
chondrial fraction, while PEA oxidation was almost completely 
blocked. Pretreatment with clorgyline strongly inhibited 
5-HT oxidation, while activity to PEA was unaffected, and 
peaked at the high density fraction. 
The use of lung mitochondria avoid contamination with 
membranous material found in synaptosomal preparations. 
These results confirm the separation of substrate-specif1c 
MAO activity In heterogenous mitochondrial populations. 
It is interesting that brain and lung seem to have MO B 
in a denser mitochondrial population. One could speculate 
that differing lipid 1 protein ratios may be involved. 
Student and Edwards added sub-synaptosomal fractionation 
to the studies of rat brain and found no selective 
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localization of either type MAO on the synaptic plasma 
membrane (Student & Edwards, 1977). Consequently, the 
difference in Type A to Type B MAO proportions seem to be 
inherent in the mitochondria themselves. Synaptosomal 
mitochondria seem to have more MAO A and less MAO B 
relative to non~synaptosomal mitochondria. 
Upon comparing the specific activity of synaptosomal 
MAO to whole brain homogenates, the ratio of MAO B to 
MAO A in the synaptosomes was 43$ that of the homogenater 
ratio, reflecting a doubling of synaptosomal MAO A specific 
activity. Free mitochondria and homogenate had the same 
ratio, 
The ratio of MAO B to MAO A in synaptosomes from cere- 
helium was 400$ the ratio in cortex. Homogenates of these 
regions gave only a 30$ difference. These results demonstrate 
that the use of brain homogenates to assess MO activity 
can obscure differences in activity at the significant 
cellular location - the synapse. 

LIPIDS AND MAO HETEROGENEITY 
After Tipton demonstrated that electrophoretic mobility 
was inversely related to phospholipid content (Tipton, 
1972), and that chaotropic treatment caused a loss of 
electrophoretic heterogeneity (Houslay & Tipton, 1973)» 
it became important to explore the role of lipids in the 
binary system of MAO generated from pharmacological data. 
The blphasic inhibition by Clorgyline and Deprenyl of 
rat liver MO activity to TYR is abolished by chaotropic 
treatment (Houslay & Tipton, 19735 Tipton, Houslay & 
Mantle, 1976), Eluting a solubilized enzyme from DEAE- 
cellulose with Triton X-100 also caused a loss of the 
selective response to inhibitors (Houslay & Tipton, 1975). 
MAO activity became less sensitive to clorgyline and 
more sensitive to deprenyl, suggesting a loss of MAO A 
activity by delipidation, 
Youdim studied the inhibition of the multiple electro¬ 
phoretic forms of rat liver MAO by clorgyline. Clorgyline 
inhibition of both DA and KYN oxidation was Inversely 
related to mobility (Youdim, Holzbauer & Woods, 197^). 
Coupled with the inverse relation of mobility to phospho¬ 
lipid content, the idea arises that the absence of lipid 
decreases clorgyline sensitivity, Youdim found this to 
be the case in cat brain MAO (Youdim & Holzbauer, 1976), 
Williams and Lawson studied the class of compounds, 
propargylamines, of which clorgyline is a member, and ' 
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found that inhibitor potency correlated with lipophiliclty 
(Williams & Lawson, 1975). 
Theoretically, lipids could account for multiple 
activities in one protein by stabilizing one active site 
versus another, or, one configuration of the site versus 
another configuration. If the second ease were true in 
MAO, one would expect the transformation of the A activity 
into B activity upon delipidation with an increase in 
activity to B form substrates, Ekstedt and (Ireland tested 
this using delipidated rat liver mitochondrial membranes 
with MAO still bound (Ekstedt & Oreland, 1975). The 
B-type activity was recovered completely, but no A-type 
was retained. When the B-form was Inhibited with deprenyl 
before delipidation, and the membrane-bound MAO then 
extracted, no MAO activity was observed, Thus no B 
activity was produced from transformation of A-type 
activity by delipidation. On the other hand, clorgyllne 
pretreatment had no effect on MAO B activity. 
White and Glassman applied a variety of approaches to 
elucidate the effects of solubilization techniques on the 
microenvironment of MAO. The properties of MAO in intact 
mitochondria were compared to MAO solubilized with a 30- 
50.^ yield by 3$ Triton X-100, With low concentrations of 
either deprenyl or clorgyllne, it was possible to selectively 
determine the Michaells constants of substrates to each 

type of MAO activity. Solubilization did not change the Km's 
of 5raHT‘or PSA and the ratio of activities to the substrates 
were similar. The sensitivity fco inhibitors was unchanged 
and biphasic curves to common substrates were preserved 
(White & Classman, 1977). Therefore both types of MAO 
activity were relatively intact after solubilization. 
Double-labelled mixed-substrate experiments can assess 
Type A and Type B activity in the same incubation mixture. 
In intact human brain mitochondria9 PEA and 5~HT are 
oxidized independent of each other, suggesting at least 
two active sites corresponding to MAO A and MAO B (White & 
Wu, 1975)« It was not possible to separate the activities 
by molecular size using gel filtration, or by differences 
In net surface charge as determined by electrofocusing. 
These results indicate that different MAO sites could be 
part of the same macromolecule (White & C-lassman, 1977). 
A variety of treatments were found to preferentially 
inactivate 5“HT oxidation without affecting PEA MAO 
activity. Solubilization itself caused a slight decrease 
in the 5~HT t PEA activity ratio. Incubation In SDS, an 
ionic detergent, and sonication decreased MAO A activity 
and inhibitor selectivity. At low concentrations, sulfhydryl 
reagent caused a selective A-site inhibition in both MAO 
preparations, preventable by high levels of 5-HT , but not 
PEA, Thiols and anionic phospholipids could protect -the. 

A-site in the solubilized MAO from inactivation by 
either high salt concentrations or prolonged incubation 
without substrate (White Sc Glass'man, 1977). 
The significance of this work lies in its presentation 
of evidence for two independent active sites resulting 
from differences in both protein conformation and lipid 
environment. The A-site has easily oxidized sulfhydryl 
moieties, and is highly susceptible to membrane pertur¬ 
bations. Veryovkina was able to inhibit MO A activity to 
c; 
5-HT by blocking 3 sulfhydryl groups per 1 x 10"' grams of 
protein, while E-site inhibition required the blocking of 
5 groups (Veryovkina, Abdel Gamed & Gorkin, 1972), 
Houslay prepared a model to test the role of lipids 
in the selectivity of clorgylin and deprenyl. Pure 
2+ 2+ 
Ca -Mg ATP-ase from rabbit sarcoplasmic reticulum can 
be prepared in various lipid bilayers to give protein 
surrounded by a phospholipid annulus. By choosing the 
components, one can provide either a fluid or rigid lipid 
microenvironment for the enzyme at a given temperature. 
The activity of the ATP-ase Is lowest at temperatures 
that make the lipid annulus rigid, and is maximum in 
fluid lipid environments. The effects of molecules on the 
fluidity/rigidity of the annulus can be sensitively monitered 
by changes in ATP-ase activity. 
At temperatures that force a rigid annulus of the 

phospholipids dimyrlstoyl lecithin (DML) and dipalmltoyl 
lecithin (DPL), clorgyline and deprenyl were able to 
activate the ATP-ase} while increasing bilayer fluidity. 
Dose-response curves revealed that clorgyline affected 
activation and fluidization at concentrations two orders 
of magnitude less than deprenyl. The difference in potency 
could not be explained by the small differences in the 
partition coefficients for the drugs (Houslay, 1977), 
This model suggests that the inhibitor selectivity is 
not a protein-mediated event, but stems from the differing 
potencies for lipid perturbation. As clorgyline is a 
Type A inhibitors the model supports the hypothesis that 
the A-slte is more lipid-dependent for Its activity, 
Huang, Eiduson and SHih introduced the use of electron 
spin resonance (ESR) techniques to study MAO, Spin-labelled 
p-hydroxyamphetamine (SHA), a reversible MO inhibitor, 
was used as a probe of the activity of a partially 
purified , solubilized rat brain MAO (Huang, Eiduson & 
Shih, 1976). 
A characteristic signal is quenched when SHA is bound 
to the enzyme. The change in signal is proportional to 
changes in the enzyme-inhibitor complex, so quantification 
of enzyme-probe and enzyme-substrate interactions is 
possible. 
When SHA concentration was plotted against enzyme-Inhibitor 
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concentration* the probe was found to bind to MO in a 
triphasic curve,felt to represent three different affinity 
sites for SHA in the non-homogenous enzyme preparation. 
ESR is particularly good for studying the active site 
of an enzyme in situ. Huang and Elduson identified and 
characterized three binding sites by intensive and extensive 
parameters (Huang & Elduson* 1977)* 
Each binding site has a specific affinity that Is a 
function of temperature according to the Gibbs-Helmholtz 
relationship t 
d In K 
where &H° is the apparent heat of formation of the site-SHA 
complex; K is the apparent association constant; R is the 
gas constant, and T is temperature. The slope of InfK 
versus - will give the heat of formation (aH°) at each 
T 
binding site. 
When In K was plotted against 1/T, three straight lines 
of different slopes were observed, characterizing three 
distinct binding groups -e<,p , # . The intersection of the 
lines reflect the temperature at x^hlch one site predominates 
over another* called the transition temperature. The 
transition temperature is associated with changes in the 
lipid domain of biomembranes that have been found to 




Pretreatment with clorgyline and deprenyl caused prefer¬ 
ential Inhibition of the binding sites, withe* left after 
clorgyline and {3 left after deprenyl. This,"-supports the 
concept of two sites differing in lipid microenvironment, 
The A site seems to be composed of |3 and # , and the B site 
composed of (X and Y That both sites share supports 
the data that- 5“HT and PEAcan be substrates at either site. 
The role played by the lipid microenvironment of MAO in 
the intact mitochondrial outer membrane In the generation 
of substrate specific forms is of vital clinical importance. 
Any change of enzyme activity found to correlate with a 
specific clinical state could be interpreted in terms of 
either a change in environment or a change In MAO protein. 
Alternatively, changes in activity due fco membrane alterations 
might go unnoticed if MAO studies are performed only on 




The impetus for the study of the multiple forms of 
MAO originated in the hope that development of substrate- 
selective or tissue-selective inhibitors would lead to 
more useful tools for neurochemical research and to safe, 
clinically helpful psychotropic drugs. It was necessary, 
therefore, to study the effects of MAO Inhibitors In 
vivo, 
Collins, Sandler and Youdlm compared the in vitro 
inhibition of the five bands of electrophoretically 
separable rat liver MAO, to inhibition of the same bands 
from rats pretreated with intrapelfconeal injections of 
tranylcypromine, pargyline and ciorgyllne (Collins, 
Youdim & Sandler, 1972). 
The In vitro sensitivity of the bands to Inhibitors 
varied widely with no correlation to the binary classifi¬ 
cation of Johnston. While distinct variation in the 
inhibition of the bands was found In vivo, these variations 
did not correlate with the apparent K^’s of each inhibitor 
to each band as determined in vitro. 
The authors interpreted their results as evidence for the 
the in vivo significance of the electrophoretlcally generated 
forms of MO, postulating that If the forms were artefactual, 
It might be expected that all forms would be inhibited 
to the same extent. Clearly, later research has proven the 
role played by phospholipids, Triton X-100 and NTZ staining 

so 
in the generation of these forms, 
Yang and Neff demonstrated that rat brain MO can be 
classified into the A/3 system. Each type is responsible 
for the metabolism of different amines and can be preferen- 
tially blocked (Yang & Neff, 197^). 
Intravenous clorgyline gave an increase in brain 5“HT, 
NE and DA with a concomitant decrease in 5"HIAA and 
3,4—<3ihydroxyphenylaoetic acid (DOPAC). Deprenyl had no 
effect on 5~HT or NE, but there was a significant increase 
in brain DA and decrease of DOPAC, Thus DA appears to be 
a substrate for both MO A and'TB. This was substantiated 
both by blphaslc inhibition curves to clorgyline and 
deprenyl in vitro, and by the observation that DA levels 
were greatest in the brain after pretreatment with both 
inhibitors. 
The in vivo results correlated with the in vitro esti¬ 
mation of MAO inhibition using homogenized brain from 
pre-treated rats. The metabolism of Injected PEA was 
found to be decreased by deprenyl, while unaffected by 
clorgyline. 
Roth and Gillis elegantly confirmed these findings 
using perfused rabbit lungs. This system permits the 
accurate measurement of Inhibitor, substrate and metabolite 
concentrations. Consequently, the pharmacokinetic problems 
of drug metabolism and distribution Inherent in intact 
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animal studies are avoided while maintaining the advantage 
of an intact cell preparation (Roth & Glllis, 1975). 
Roth and Qillis performed a douple-labelled mixed- 
substrate experiment with equimolar concentrations of 
3 l4 
H -5-HT and G -PEA perfused through the same lung and 
observed no competition of oxidation. The addition of 
harinaline „ a reversible MO A inhibitor , selectively 
decreased 5-HT oxidation without affecting activity to 
PEA.the results substantiate the in vivo significance 
of two separate enzyme activities. 
The role of Type A and Type B MAO in the in vivo 
regulation of biogenic amines was studied using specific 
behavioral syndromes in the rat caused by increased 
synaptic 5=,HT and DA respectively. 
Green and Youdim reported that the $~HT hyperactivity 
syndrome produced by tranylcypromine (MAO A and B inhibitor) 
and tryptophan load could not be Induced by tryptophan 
loading and clorgyline pretreatment. The doses of clorgyline 
were shown to give 100$ inhibition of 5“HT MAO activity 
in vitro. It was necessary to achieve 100$ Inhibition of 
both MAO A and 3 with clorgyline and deprenyl before the 
5-HT behavioral syndrome could be induced by a tryptophan 
load. Clorgyline and tryptophan did not elevate brain 5-HT 
to the levels found after tranylcypromine or clorgyline + 
deprenyl (Green & Youdim, 1975). Analogous findings for 

the behavioral syndrome produced by increased functional 
DA in the rat brain were reported (Green, Mitchell, Tordoff 
& Youdim, 1977). These authors found that the recovery of 
Type A MO activity was 4,5 days and of Type B was 8,5 
days. The rate of recovery from irreversible inhibition 
is generally thought to reflect the rate of new synthesis 
of enzyme. While the two forms seem to be under different 
regulation, one cannot discriminate 'among, the alternatives 
of new protein synthesis, renewal of lipid moiety attach¬ 
ment, or different rates of specific mitochondrial 
regeneration, 
Nonetheless,the experiments show that both 5“HT and DA 
can be metabolized by both types of MO in vivo. It is 
possible that MO A and B function as an integrated unit 
In the same cell (HousXay, Tipton & Youdim, 1976), 
Pathological states could arise from an imbalance between 
the two forms at a specific site. 

HU MM PLATELET MO 
The discovery of significant MAO activity in the human 
platelet is of particular significance for neuropsychiatrl 
research, primarily due to the ease of obtaining samples 
for study. Platelet MO can be helpful both diagnostically 
to characterize certain disorders, and therapeutically to 
assess the efficacy of drugs purported to act via altera¬ 
tions in MAO. Naturally, the degree of similarity between 
platelet MAO and MAO from other tissues, especially the 
brain must be determined. 
Robinson compared rat liver to human platelet MAO 
activity towards BZ, TYR, TRIP and 5-HT. Though the 
specific activity was greater in rat liver, the rank order 
was the same. The K, *s for BZ and TYR were virtually the 
same, but those for TRYP and 5"HT were significantly 
different. Rat liver and human platelet MAO responded 
equivalently to KAO inhibitors (Robinson, et, al.,1968). 
The authors felt the evidence pointed to similarities 
between the KAO's, though cross-species comparisons are 
difficult to assess. Of more importance was the good 
correlation found for the In vivo inhibition of platelet 
MAO and urinary excretion of TRYP. It appears platelet MAO 
is responsible for the peripheral metabolism of some 
biogenic amines, 
Collins and Sandler prepared a solubilized MAO from 
human platelet mitochondria using two hours of sonication 
in the presence of 1% Triton X™100 and gel filtration 
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through Scphadex G-200, A single peak of enzyme activity 
with MW-235»000 was obtained, representing a 12-fold 
purif1ca11one though 90% of the original activity was 
lost (Collins & Sandler, 1971). The relative activities 
toward DA, TRYP, TYR, KYN and BZ did not change through 
various steps in the purification. A more labile form was 
not felt to have been lost. Unfortunately, neither 5-HT 
nor NS, substrates preferentially oxidized by MO A, were 
tested . 
The purified MAO showed a biphasic heat inactivation 
curve not apparant in MAO from lysed platelets, suggesting 
some change in the response to physical factors. The 
kinetic constants of substrates and inhibitors were in 
good agreement with those obtained by Robinson (Robinson, 
et „ al,, 1968), 
Polyacrylamide gel electrophoresis using NTZ staining 
with TRYP as substrate resulted in a single band of activity. 
It is interesting to speculate why the identical purifica¬ 
tion technique used by Youdim to prepare his multiple 
forms in rat liver MAO yielded but one band In the platelet. 
This may reflect mitochondrial homogeneity in the platelet. 
Amitriptyline, a tricyclic antidepressant:, inhibits 
human platelet MAO in vitro (Edwards & Burns, 197^). The 
effect was equivalent for platelet sonicates, purified MAO 
preparations and perchlorate-treated enzyme, so the 

inhibition was not due to membrane or lipid changes. 
Amitriptyline inhibition is reversible for BZ, TRIP 
and PEA, but the mechanism was competltve for BZ and ' 
non-competitive for TRIP and PEA. The difference in 
kinetics led to the proposal that platelet MAO has two 
catalytic sites,- one for BZ and another for TRYP and PEA, 
Mixed-substrate experiments revealed that BZ and TRYP 
were mutually competitive, with PEA mutually non-corapetitive 
with BZ and TRYP. These results imply that BZ and TRYP 
share a site with another for PEA (Edwards & Chang, 1975). 
It is difficult to reconcile the two experiments with 
respect to inhibition of TRYP MAO activity. 
Amitriptyline inhibition of platelet MAO was replicated 
in MAO B from human brain (Roth, 1976), When mixed-substrate 
experiments for BZ and PEA and MAO inhibition by amitrip¬ 
tyline were performed at high Op concentrations, all 
inhibition was found to be competitive. Thus, at high Op 
levels amitriptyline, BZ and PEA seemed to Interact at 
one site, 
The effect of 0^ is interpretable interms of the 
reaction mechanism. MAO possesses a "ping-pong" kinetic 
mechanism (Tipton, 1972j Yasunobu & Oi, 1972), as summarized 
by a two-step reaction* 

* RCHO (1) E - F -i- RCH2NH2->EA E’P1P2~> E-FH2 + NH^ 
E + A ' E * + P„ + P 
1 2 
Deamination of Amine Reduction of Flavin cofactor 
(2) E*»Fh2 + 02~^ E'B --> EQ -* E~F + H2C>2 
Reoxidatlon of flavin by oxygen 
In such reactions, as the 02 concentration decreases, 
the affinity for the substrate A increases {Tipton, 1972), 
protecting the reaction against variations in the C*2 level 
of its environment. The for 02 is about 0.250 mM, 
equivalent to the concentration of dissolved 02 in - - 
air»»satinvited water at physiological temperatures. Both 
in vivo and in assay media, MAO will not be saturated by 
02. Consequently, the overall rate of reaction is dependent 
on the concentration and K of both 0o and the substrate. 
m 2 
By raising the concentration of 02 to super-physiological 
levels, Roth was able to saturate MAO and effectively keep 
it in the oxidized form. The deaminating step became 
rate-limiting so the competition between substrate and 
inhibitor could be observed. Kinetic analysis of the data 
revealed the theoretically expected linear competitive 
inhibition of BZ, PEA and amitriptyline at one site on the 
oxidized form of MO (Roth, 1976). 
These results indicate that mixed-substrate and inhibitor 

experiments interpreted as evidence for multiple sites or 
forms must take into account the oxidative state of MAO. 
An inhibitor binding to either E or E' will give competitive 
or uncompetitive inhibition respectively. Non-competitive 
inhibition results from binding to both forms of the enzyme 
(Piszkiewlcz* 1977). In the case of MAO, E corresponds to 
the oxidized form of the enzyme, and E5 corresponds to the 
reduced form. 
It is likely that both KAO A and B will exist in two 
conformations, one oxidized (E), and one reduced. (E’)> 
Binding to Es with lowered affinity at high inhibitor 
concentrations (i,e, second substrate or inhibitor like 
amitriptyline), will produce the hyperbolic replot data 
observed in the human platelet (Edwards & Burns, 197*0 
and human brain (Roth, 1976). The non-competitive kinetics 
result from both the decreased affinity to E*, and the 
decreased rate of product formation. Possibly, the two' 
conformations of platelet MAO reported by Kebayashi and 
Eiduson reflect change's In the oxidative state (Kobayashi & 
Eiduson, 1977). 
Donnelly and Murphy utilized kinetic and inhibitor 
studies to characterize human platelet MAO as Type B. MAO 
was prepared by short sonication and freeze-thaw without 
attempts to purify and delipidate. The loss of labile or 




Essentially 100% of MO activity to TYR, DA, TRYP, 
-6 PEA and BZ was Inhibited by 1x10 M deprenyl, while 
1x10 M clorgyline and 30 minute prelncubatlon caused 
no inhibition. Both inhibitors gave single sigmoidal 
curves for common and B-slte substrates. The K *s for PEA 
and TRYP in the platelet are in agreement with those 
reported for human brain and liver M0 (White & Classman, 
197?). The evidence that platelet MO corresponds to Type 
B very similar to MO B found in other human tissues, 
especially the brain, is quite strong. 
The homogeneity of human platelet MO has particular 
significance for the question of enzyme multiplicity. 
Differential proportions of M0 A to MAO B have been shown 
to exist in many tissues of various species, though few 
preparations are exclusive for either type (for reviews, 
Achee, Gabay & Tipton, 1977l Fowler, Callingham, Mantle & 
Tipton, 1978), Among these experiments of nature are 
tissue culture preparations of rat C6 glial cells and 
mouse neuroblastoma N1E-115 cells, both MO A,(Donnelly, 
Richelson &. Murphy, 1976),and the human platelet. The 
discovery of a pure Type A human cell would afford the 
opportunity to determine the molecular basis of the.-i 
distinction between MO activities. 





Neuropsychiatric research on platelet MO has been 
spurred by the repeated finding of reduced MAO activity 
in adu.lt> chronic schizophrenia (Murphy & Wyatt, 1972; 
Meltzer & Stahl, 197^; Sullivan, Stanfield & Dackis, 1977), 
and bipolar depressive illness (Murphy & Weiss, 1972; 
Leckman, Gershon, Nichols & Murphy, 1977). Consensus on 
this topic is far from complete (White, Mcleod & Davidson, 
1976; Owen, Bourne, Crow, et. al., 1976; especially the 
Correspondence section, New England J, of Med. 298(20)11150). 
Family and twin studies have suggested that reduced platelet 
Mo activity may be a biological marker for vulnerability 
to psychiatric disorders (Wyatt, et. al., 1973; Buchsbaum, 
Coursey & Murphy, 197 6). 
Comparison of the properties of platelets and serotonergic 
synaptosomes suggest that the platelet can serve as a model 
for the transport, storage, metabolism and release of 5“HT 
by CNS serotonergic neurons (Pletscher, I960; Sneddon, 1973; 
Stahl, 1977). MO plays a; role In the uptake- of - monoamines 
of neurons (Trendelenburg, 1972) by altering their intra¬ 
cellular concentrations. This has not been studied as yet 
In the platelet, though it could help explain the elevated 
levels of 5~HT reported in a subgroup of autistic ehidren 
(Hanley, Stahl & Freedman, 1977). 

Primary childhood autism is a syndrome manifested 
during the first two years of life by disturbances in social, 
emotional and cognitive development (Rutter,1974) . The aim 
of this study is to explore MAO activity in autistic 
children and their families to determine the occurence of 
a subgroup who either have variant levels of activity 
against normals, or arc variant in relation to their 
family, 
SUBJECTS AND METHODS 
POPULATION 
Twenty children (18 boys, two girls) with early child¬ 
hood autism were the subjects of this investigation. They 
ranged in ago from 4 to 23 years (mean=12.8 years). Nine 
children were unmedicated, six were on one drug and five 
were taking more than one. Aside from vitamins and anti¬ 
histamines, medications included neuroleptics and anti¬ 
convulsant s . 
All children satisfied the diagnostic criteria for 
primary childhood autism5 onset of symptoms of develop¬ 
mental disability before two years of age; absence or 
marked limitation of social relatedness; profound language 
delay and Idiosyncrasies; need for environmental stability; 
movement disturbances; islets of better functioning; 
relatively normal motor landmarks. 
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Control subjects (15 Rials,' 5 female) consisted of 
children (8 less than 15 years) and adults with no personal 
medical or psychiatric disturbances and no known family 
history of autism, aphasia, or other developmental 
disturbances. 
Platelet MO was assayed in the parents and normal Ar 
sibllngs of nine children with autism to study the genetic 
contribution to MAO activity in these children. 
METHOD 
Consent was obtained from all participating individuals 
after explaining the purposes, procedures and risks of the 
study. Samples of blood for MAO assay from the index 
children were obtained as part of a broader initial eval¬ 
uation and at subsequent occasions when the clinical 
indications for venipuncture were present. 
Blood was obtained via standard venipuncture, using 
a 21-guage, siliconized needle, and collected in glass 
tubes containing 10.5 mg of EDTA, The blood was immediately 
placed on ice,-Within three hours of collection, the platelets 
were harvested by centrifugation in succession at 175 and 
300 g, each for ten minutes, and 4,000 g for twenty minutes 
to isolate the platelets. Platelets were washed in 2 ml of 
cold isotonic saline, reisolated by centrifugation, and 
stored as a pellet frozen for a maximum of two weeks. 

Platelets disrupted by sonication were incubated in the 
presence of 1,67 x 10^H Tyramine labelled with in a 
total of 1.5 21I of 0,05 M potassium phosphate buffer, 
pH 7.4. Platelet protein was assayed by the method of 
Lowry (Lowry, et. al.,1951), and platelet MAC was reported 
as nanamoles of deaminated product formed per milligram 
of platelet protein per 60 minutes of incubation (Roth, 
et, al., 1976), 
RESULTS 
Analysis of MAO activity correlation to age was not 
significant for the entire population of patients, family 
members of afflicted children and index patients. The lack 
of correlation was maintained for autistlcs, male aucistics, 
family members alone, normals alone, and normals discriminated 
by sex. Sex differences revealed women (mean,:29.322) to 
have a significantly higher activity than males (mean,19.401). 
Group means for normal males, male autlstics and male 
family members were not slgnificantly different. The sample 
size for autistic females was too small for adequate statis¬ 
tical analysis (Table 1). Thereywas no significant difference 
between autistic males and normal males less than 24 years 
old (Table 2). MAO activity for normal males appeared to 
be normally distributed, though the distribution for male 
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autistics was not as clearcut (Figure 1). 
MO levels were assayed for parents, normal siblings 
and index children in nine families (Fig.2), Analysis of 
variance showed no significant clustering of MAO activity 
by family (F=1,313 , NS), 
DISCUSSION 
Normative data to assess the relative contributions 
of age and sex on platelet MAO activity has been accumulated. 
Using BZ as a substrate, Robinson has studied a total of 
71 men and 91 women, 21 to 84 years of age (Robinson,et. al,, 
1971s Robinson, 1975). He found a significant correlation 
with age in both populations, and that females have 27% 
higher MAO activity. It should be noted that the increase 
in activity is most pronounced after the age of 55» especially 
In women. A study of 680 normals through the age of 60 did 
not reveal any correlation with age in either sex, though 
females had activities 20%> higher than males (Murphy, Wright, 
et. al., 1976). The frequency distribution significantly 
deviated from normal, resulting from a skewing of the curve 
by a few high values and more low values than expected. 
Statistical tests failed to reveal a bimodal distribution 
Roth, Young and Cohen extended the normative data to 
children, with an eye to any influence of puberty on MAO 

6>3 
activity (Roth* Young & Cohen, 1976), The variability of 
MAO activity was 17.7% for all children, though it was 
30% for females and only 10% for males. No correlation 
between age and activity was found through the age of 40 
years. Females were found to have 2J% higher activity at 
all ages, Prepubescent and pubescent females had $2% and 
6lfo greater activity respectively. There was a significant 
decrease in activity in post-pubertal females. Nothing in 
the present study is in disagreement with the data previously 
reported. 
This study corroborates previously reported work on MAO 
activity in autistic children (Boullin, et.al.,1975* 
Cambell, et, al,,19765 Cohen, Young & Roth, 1977? Lake, 
Ziegler & Murphy, 1977) showing no difference in activity 
from normals. The non-signifleant analysis of variance for 
activity in families reported here does not agree with the 
results of Cohen (Fig.25 Cohen, Young & Roth,1977). Cohen 
included two normal families in his study, and it is con¬ 
ceivable that the significant clustering he reported 
reflects a difference between normal and autistic families. 
It appears that MAO does not contribute to the elevated 
5-HT found in some autistic children. Simultaneous measure¬ 
ments of 5~HT and MAO would be most illuminating. 
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Table 1.- Group Means for Males 
Normal 
Platelet MAO Activity 
nmoles/ mg protein/ hr. 
Autistic Family Member P 
19,401+ 9.173 
(N = 15).... 
24.814+ 10,585 
(N = 18) 
it it -X- ■If it it -S- it- NS 
19.401+ 9.173 
(N = 15) 
22,974+8,459 
(N =' 12) 
NS 
24.814+10.585 22.974+8.459 NS 
Table 2.-Group means for Males, 24 years 
Platelet MAO Activity 
nmoles/ mg protein/ hr 













Fig*. 1,~ Distribution of MAO activity In Normal & Autistic Males 




Fig. 2. Platelet MAO activity grouped by families. 
For familial clustering, F-l.3^3* P~NS 

BIBLIOGRAPHY 
(1) Achee» F; M. ,& Gabay, S. (1977)* Biochcm. Pharm,26:1637-1644 
(2) & Tipton, K,F, (1977)? Prog, In 
N e u r o b .1 o 1 o gy 8 % 3 2 5 
(3) Blatchford ,D. , HoXzbauer, M,& Youdlm, M.B.H. (1975)* 
Br, J, of Pharm. s 2 51P 
(4) BoulllnSDJ, Bhagavan,HN, Coleman,M, O’Brien,, RA & Youd 1m,MBH 
(1975)^ Medical Biology 53*210-213 
(5) Bourgoin, S, Faivre-Bauman, A. , Benda, P0, Glowlnskl, J, , 
Hamon, M. (i 974) s J , Neurochem. 23-1319«32? 
(6) _, Artaud, F, , Adrien, J,, Hery, F., Glowinski, J, , 
Hamon, M, (1977)? J, Kaurochem 28 §415“422 
(7) Buchsbaum, MS, Coursey, RD, Murphy, DL (1976)5 Science 194:339 
(8) Campbell,M? Friedman,Eg Green,WH? Small,AM? Burdock,SI (1976)3 
Neur o p sy c hob 1 o 1 o gy 2 s 23 9 ~2 46 
(9) Cohen,DJ1 Young, JG 5 Roth, JA (1977)* Arch, of Gen. Psych,343534 
(10) Collins,GGS? Sandler,M (1971)? Biochem, Pharm, 20*289 
(11) 1 Youd1m,MBH5 Sandler,M (1972)s Bloch, Pharm, 2151995 
(12) Diaz-Borges,JM? D*Iorio,A (1972): Adv, in Bloch, Psychopharm, 
5 **79 
(13 )__ J___ (1973)? Canad , -J of Bioch. 51 ; 1089 
(14) Donnelly, CH ; Rlchelson,E{ Murphy,DL (1976)s Bio, Pharm.25?1639 
(15) _________ J Murphy , DL (1977) : Bioch. Pharm 263853 
(16) Edwards, DJ; Burns,MO (1974): Life Scl 15:2045 
(17) _; Chang,S-S (1975)? Bioch, & Blophys, Res, Comm.65:1018 

68 
(18) Eiduson,S (1972)* Adv, In Bloch, Psychopharm. 5:271 
(19) Ekstedt,Bj Oreland,L (1975)5 Bloch. Pharm. 25s 119 
(20) (1976); Bloch, Pharm. 25*1133 
(21) Dermick,RG; Mayer,RJ (1977); Blochem. J. 161:167 
(22) Edmond son,DEj Singer,TP (1976): FEBS Letters 64:255 
(23) Fowler,CJj CallIngham *3A j Mantle,TJ; Tipton, KF (1978) 
Bloch., Pharm 27 s 97 
(24) Fuller, RW (1970): Bloch, Pharm. 19:2934 
(25) Gabay, Sj Aehee, FMj Mentes, G (1976)s J of Neurochem 27*415 
(26) Gallagher9 BM (1977) * Bloch, Pharm, 26s935 
(27) Gear, ARL (1970): Blochem J, 120 s 577 
(28) Ghosh, SKj Guha , SR (1978): Bloch. Pharm, 2?si12 
(29) Green, ARt Youdim, MBH (1975)? Br. J. of Pharm. 55:415 
(30) __ i Mitchell, BD ? Tordoff, FC j Youd 1m, MBH (1977) 1 
Br. J, of Pharm. 60s343 
(31) Greenawalt, JW (1972)3 Adv, in Bloch, Psychopharm, 5 5207 
(32) Gripois»D (1975)s Comp. Bloch, Physiol. 51c:143 
(33) Guha, SR: Ghosh,SK (1970); Bloch, Pharm. 19:2929 
(34) Hall, DWR.J Logan,BW 1 Parsons, GH (1969) * Bloch. Pharm. 18s 1447 
(35) Hartmann, BK; Udenfrlend,S (1972)s Adv, Bloch, Psychopharm. 
5*119 
(36) Hanley, HG; Stahl,SM; Freedman, DX (1977)sArch, Gen. Psy. 34:521 
(37) Houslay,HDj Tipton,KF (1973): Blochem J 135:173 
(38) ; (1975)J Blochem. J. 145*311 
(39) ? Youdim,MBH (1976): Life Scl 19:467 

(40) _ (1977)s J Pharm Pharmac 29 :664 
(41) Huang,RH; Elduson,S; Shlh,JC (1976): J of Neuroohem 26 i 799 
(42 ) _____5 Elduson,3 (1977) : J of Biol, Chem. 252 1284 
(43) Inoue Fj Robinson,JB; Dost, KA (1976): J Pharm Pharmac 28:521 
(44) Jain,M? Sands,Fj Von Korff.RW (1973)J Analyt, Bloch. 52:542 
(45) i 5(1974)5 J of Neurochem 23:1291 
(46) ___ _ (1977)* Life Sci 20:1925 
(47) Johnston,J.P (1968): Bloch„ Pharm. 17:1285 
(48) Kim,HC s D'Iorio, A (1968)5 Canad. Jo f B1oe h,46:295 
(49) Knoll s J 5 Magyar ,K (1972): Ad_v» Bloch, Psychopharm 5 :393 
(50) Kobayashi,K5 Elduson, S (1977)s Bloch, Medicine 18:378 
(51) Kroon,MC\ Ve1dstra, H (1972): FEES Letters 24:173 
(52) Lagnadc9JR? Sourkes,TL (1968): Can,J, B1och, Phys1o1, 36:587 
(53) _\ Oka mo to , M 5 Youd im, MBH (1971) : FEBS Letters 17:117 
(54) Lake,CR ? Ziegler,MG 5 Murphy,DL (1977)sArch GenPsych 34 j 553 
(55) .Leckman, JF1 Gershon,ES 5 Nichols,AS? Murphy,DL (1977) 
Arch, Gen,Psych * 34:601 
(56) Lowry9DH? Rosenbrough,MG\ Farr,ALj Randall,RJ (1951) 
J of Biol. Chem„ 193:265 
(57) Lyles,GA? CallIngham,BA (1975): J Pharm Pharmac 27:682 
(58) ; Greenawalt, JW (1977): Bloch, Pharm. 26:2269 
(59) Mantle,TJ; Wilson, K 5 Long»RF (19759-): Bioch. Pharm 24:2031 
(60) j j (1975b): Bloch, Pharm 24: 2039 
(61) ;HouslaytMD; Garrett,NJ j Tipton,KF (1976): 
J Pharm Pharmac 28:667 

70 
(62) ? Garrett, NJ i Tipton,KF (.1976) j FEBS Letters 64 s 227 
(63) McCauley,R3 Rackor , E (1973)* Molec & Cell. Bloch. 1s 73 
(64) MeEwen,Jr,CM; Sasak1, G s Lenz,Jr ,,WR 91968 jJ BiolChem 2433 5217 
(65) ? ?Jones,DC (1969): Bloch, Easton 8 s3952 
(66) Meltzer#HY? Stahl,SM (1974) 3 Res , PattiPharm 7 3 4l9 
(6?) Murphy,DLj Wyatt,RJ (1972): Nature 238:225 
(68) ; Weiss s R (1972): Am J of Psych 128 s i351 
(69) ; Wright,C; Buchsbaum,M; Nichols,A 5 Costa,JL? Wyatt,RJ (1976) 
Bloch, Med, 16:254 
(70) Neff.NHj Yang H-Y. T (1974)i Life Scl l4s206i 
(71) _____5_____ 1 Fuentes,JA (1974): Adv Bio Psychopharm 12:49 
(72) Oliveerona,T; Oreland,L (1971): Biochemistry 10s332 
(73) Oreland,Lj 01ivecrona,T (1971): Arch Bloch Blophys 142:710 
(74) __________ _(1972 ) j Adv Bloch Psychopharm 507 
(75) Owen,F; Bourne,R; Crow,TJj Johnstone EC; Bailey,AR? Hershon,HI 
(1976) :Arch GemPs.ych 33 :1370 
(76) 3 3Lai, JCKj Williams,R (197?):Bloch,Pharm 26 3289 
(7?) Piszkiewicz,D (1977)* Kinetics of Chemical and Enzyme-Catalyzed 
Reactions 3pp.79-149;Oxford U, Press ;NY 
(78) PXetscher,A (1968): Br J of Pharm 32:1 
(79) Robinson,DS; Lovenberg, V/; Kaiser,H; Sjoerd s'ma , A (1968) 
Bloch.Pharm 17:109 
(60) ? Davis,JM;Nies,A; Ravaris,CL; Sylcester, D (1971) 
Arch. Gen. Psych, 24:536 
(81) (1975): Fed,Proc, 34:103 

(82) Roth,JA; Gillis»CN (1975)? J ■ Pharm Exp Ther 1948337 
(83) _ (19?6): J Neurochem 27 s1107 
(84) ; Young, JG; Cohen, DJ (1.976)2 Life 5c 1 18*919 
(85) Rutter,M (1974)j Psychol, Ned, 4s147 
(86) Sandler, M 5 Youdim, MBH (1972) 2 Pharmacological Reviews 24;331 
(87) Schnaitman, C1 Greenawalt, JW (1968)* J of Cell Bio, 38 si58 
(88) Shih, JC? Elduson, S (1974); Adv. Bloch, Psychopharm 12;29 
(89) Slerens, L; D'lorio, A (1970)s Canad. J Bloch 48 *659 
(90) Singer, TP (1974)* CIBA Found, Sympos.39(New Series)*MAO and its 
Inhibitors ; p.24s Elsevier»NY 
(91) Sneddon, JM (1973)* Prog. In Neurobiology I1I5I 
(92) Squires, RF (1972); Adv Bloch Psychopharm 5*855 
(93) Stahl, SM (1977)* Arch, Gen, Psych. 34*509 
(94) Student, AK; Edwards, DJ (1977)* Bloch, Pharm. 26s2337 
(95) Sullivan,J; Stanfield, CN; Dackls, C (1977)1 
Am, J of Psych 13421098 
(96) Tipton, KF 5 Spires, IPC (1968)1 Bloch, Pharm, 17*2137 
(97) ______ _ j (1971) s in Mechanisms of Toxicity (W. N. AidrIdge ,ed , ) 
pp,13”27 j MacMIlian,London 
(98) (1972): Adv, Bloch. Psychopharm 5 til 
(99) ; Houslay, HD ; Mantle, TJ (19?6);CIBA Sym,39 (NS)sMAO . 
and its Inhibitors, pp,5~l6 
(100) Tooze, J (1973); Molecular Biology of Tumor Viruses; Gold Spring 
Harbor Laboratory, USA, pp.217 

(101) Trendelenberg, U; Draskoczy, PR; Graefe,K (1972)s 
Adv, Bloch, Psychopharm 5 071 
(102) VandenBerg, CJ (1973)* Metabolic Compartiaentat ion In the Brain; 
(R, Balazs & J. E, Cramer,ed.),pp.137-166 
Ma c Mi1lan j Londo n 
(103) Van Woert, MH; Cotzlas, GO (1966)* Bloch. Pharm. 15*275 
(104) Veryovkina, IV? Abdel Samed, M.M.; Gorkin,VZ (1972); 
Bloc him Biophys Acta 25806 
(105) White, HL; Wu, JC (1975)* J Neurochera 25:21 
(106) ; Classman9 AT (1977)* J Neurochea 29*987 
(107) ; McLeod , MN ; Davidson, JRT (1976) s Am, J. Psych 133 •. 1191 
(108) Williams, CH (1974)* Bloch, Pharm, 23*615 
(109) » Lawson, J (1975)* Bloch. Pharm. 24s1889 
(110) Williams, D; Gascoigne, JE; Williams ,ED (1975)* 
Brain Research 100 s231 
(111) Wyatt, RJs Murphy, DL; Belmaker, R; Cohen, S;Donnelly, CH; 
Pollin, W (1973)s Science 179*916 
(112) Yang, H.-Y.i Neff,NH (1974)* J Pharm Exp They 189*733 
(113) Yasunobu, KT, 0i, S (1972); Adv,Bioch. Psychopharm 5*91 
(114) Youdlm, MBH; Sandler, M (1967)* Btochera, J 105*43P 
(115) _; Collins, GGS ; Sandler, M (1970)*FEBS:SYMPOSIA 18- 
"Enzymes and Isozymes",D. Shugar,ed.;ppf 281-289 
Academic Press; London 
(116) ; (1971s Europ. J Bloch. 18:73 
(117) (1974)s Adv. Bloch. Psychopharm 11j 59 
♦ 
(118) __; Hoizbauer,Mi Wood s» HF (197^)s Adv, Bloch, Psyohppharm 
12:11 
(119) .; Collinsj ggs (1975): ISOZYMES, Vcl. Iljed. C.L. Markert, 
pps,619-636; Academic Press? NY 
(120) _) Hoizbauer, M (1976) : J. of Neural Transmission 38*193 

YALE MEDICAL LIBRARY 
Manuscript Theses 
Unpublished theses submitted for the Master’s and Doctor's degrees and 
deposited in the Yale Medical Library are to be used only with due regard to the 
rights of the authors. Bibliographical references may be noted, but passages 
must not be copied vithout permission of the authors, and without proper credit 
being given in subsequent written or published work. 
This thesis by has been 
used by the following persons, whose signatures attest their acceptance of the 
above restrictions. 
NAME AND ADDRESS 
^ "B ."t'k u>*-\ \ <o0co£&t^Sf. 
DATE 
s/ts/*6. 

